Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes
- 15 July 2005
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 239 (1-2), 55-61
- https://doi.org/10.1016/j.mce.2005.03.016
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ N G -Nitro- l -Arginine Methyl Ester-Induced Myocardial InjuryCirculation, 2003
- Spironolactone increases integrin β3 gene expression in kidney and heart muscle cellsMolecular and Cellular Endocrinology, 2002
- Spironolactone Abolishes the Relationship between Aldosterone and Plasminogen Activator Inhibitor-1 in HumansJournal of Clinical Endocrinology & Metabolism, 2002
- Fosinopril Versus Amlodipine Comparative Treatments StudyCirculation, 2002
- Aldosterone: A Mediator of Myocardial Necrosis and Renal ArteriopathyEndocrinology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.JCI Insight, 1995
- Regulation of Plasminogen Activator Inhibitor-1 Levels in Human MonocytesCellular Immunology, 1993
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985